Scientists Discover Rare Genetic Diabetes in Newborns for First Time

A rare form of diabetes linked to a genetic disorder has been identified in newborns by researchers from the University of Exeter in the United Kingdom and Université Libre de Bruxelles (ULB) in Belgium. This groundbreaking discovery reveals how mutations in the TMEM167A gene disrupt insulin production in infants, marking the first time this condition has been documented in such a young population.

The collaborative research team utilized advanced DNA sequencing techniques and stem cell research to explore the genetic underpinnings of neonatal diabetes. Their work highlights how specific mutations in the TMEM167A gene lead to the early failure of insulin-producing cells. Dr. Elisa de Franco, a key researcher in the study, emphasized the significance of these findings: “Finding the DNA changes that cause diabetes in babies gives us a unique way to find the genes that play key roles in making and secreting insulin.”

In their study, the researchers examined six children diagnosed not only with diabetes but also with neurological conditions, including epilepsy and microcephaly. All six children shared mutations in the TMEM167A gene, suggesting a common genetic cause for both the metabolic and neurological symptoms they experienced.

Insights into Insulin Production and Cell Function

Professor Miriam Cnop from ULB played a pivotal role in this research by transforming stem cells into pancreatic beta cells, which are responsible for insulin production. Using gene editing techniques, her team demonstrated that damage to the TMEM167A gene impairs the normal functioning of these insulin-producing cells. The resulting cellular stress ultimately leads to cell death, contributing to the onset of diabetes.

“The ability to generate insulin-producing cells from stem cells has enabled us to study what is dysfunctional in the beta cells of patients with rare forms as well as other types of diabetes,” Professor Cnop stated. “This is an extraordinary model for studying disease mechanisms and testing treatments.”

The research also revealed that the TMEM167A gene plays a critical role in neuronal function, while its importance diminishes in other cell types. This dual impact on both metabolic and neurological health underscores the complexity of this genetic disorder.

Publication and Support for Continued Research

The findings of this significant study were published in The Journal of Clinical Investigation under the title “Recessive TMEM167A variants cause neonatal diabetes, microcephaly and epilepsy syndrome.” The research was supported by several organizations, including Diabetes UK and the European Foundation for the Study of Diabetes, highlighting the collaborative effort to enhance understanding of this rare condition.

As researchers continue to explore the implications of these findings, the identification of the TMEM167A gene as a key player in neonatal diabetes offers new avenues for potential treatments and interventions for affected infants. This discovery not only contributes to the field of genetics but also emphasizes the importance of continued research in understanding the complexities of diabetes and its associated conditions.